IRIS
MONDA, EMANUELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.077
AS - Asia 1.694
NA - Nord America 1.034
SA - Sud America 286
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 5.113
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 1.419
US - Stati Uniti d'America 989
SG - Singapore 668
CN - Cina 431
BR - Brasile 236
HK - Hong Kong 227
IT - Italia 193
IE - Irlanda 191
DE - Germania 117
KR - Corea 109
VN - Vietnam 107
IN - India 73
GB - Regno Unito 30
FI - Finlandia 26
JP - Giappone 25
AR - Argentina 24
FR - Francia 23
MX - Messico 19
AT - Austria 18
CA - Canada 18
EC - Ecuador 14
BD - Bangladesh 11
PL - Polonia 8
TR - Turchia 8
CH - Svizzera 7
NL - Olanda 7
ZA - Sudafrica 7
LT - Lituania 6
MA - Marocco 6
SE - Svezia 6
ID - Indonesia 5
IQ - Iraq 5
CO - Colombia 4
CZ - Repubblica Ceca 4
ES - Italia 4
NP - Nepal 4
EG - Egitto 3
JM - Giamaica 3
PK - Pakistan 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
CR - Costa Rica 2
EE - Estonia 2
HU - Ungheria 2
JO - Giordania 2
LK - Sri Lanka 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
PY - Paraguay 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
VE - Venezuela 2
AL - Albania 1
AU - Australia 1
BE - Belgio 1
BW - Botswana 1
CG - Congo 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
IL - Israele 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
NO - Norvegia 1
OM - Oman 1
RO - Romania 1
SR - Suriname 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.113
Salva come PNG Salva come JPEG
Città #
Moscow 499
Santa Clara 286
Singapore 260
Hong Kong 227
Dublin 191
Hefei 140
Chandler 126
Seoul 109
New York 81
Naples 53
Bengaluru 51
Ashburn 50
Munich 44
Beijing 43
Ho Chi Minh City 43
The Dalles 31
Hanoi 23
Bremen 21
Cambridge 21
Princeton 21
Roxbury 21
Los Angeles 20
São Paulo 20
Turku 18
Rome 17
Falkenstein 15
Nuremberg 15
Dallas 14
Frankfurt am Main 10
Chicago 9
Hyderabad 9
Marano Di Napoli 9
Toronto 9
Vienna 9
Boardman 7
Brasília 7
Guangzhou 7
Salvador 7
Amsterdam 6
Atlanta 6
Belo Horizonte 6
Brooklyn 6
Caserta 6
Dhaka 6
Guayaquil 6
London 6
Milan 6
Stockholm 6
Chennai 5
Lappeenranta 5
Pratteln 5
Rio de Janeiro 5
Biên Hòa 4
Boston 4
Buenos Aires 4
Changsha 4
Denver 4
Des Moines 4
Haiphong 4
Johannesburg 4
Marcianise 4
Napoli 4
Newark 4
Porto Alegre 4
Warsaw 4
Aversa 3
Benito Juarez 3
Bexley 3
Boone 3
Brdo 3
Bắc Ninh 3
Cairo 3
Canoas 3
Casalnuovo di Napoli 3
Contagem 3
Curitiba 3
Da Nang 3
Fortaleza 3
Goiânia 3
Guarulhos 3
Helsinki 3
Manassas 3
Mexico City 3
Ninh Bình 3
Ottawa 3
Pozzuoli 3
Quito 3
San Francisco 3
Seattle 3
Shanghai 3
Tokyo 3
Vicenza 3
Wilmington 3
Alghero 2
Amman 2
Andradina 2
Anápolis 2
Augusta 2
Baghdad 2
Barbianello 2
Totale 2.773
Salva come PNG Salva come JPEG
Nome #
Diagnostic issues faced by a rare disease healthcare network during Covid-19 outbreak: data from the Campania Rare Disease Registry 141
Advanced Heart Failure in Special Population—Pediatric Age 115
Combined Effect of Mediterranean Diet and Aerobic Exercise on Weight Loss and Clinical Status in Obese Symptomatic Patients with Hypertrophic Cardiomyopathy 112
The Risk of Sudden Unexpected Cardiac Death in Children: Epidemiology, Clinical Causes, and Prevention 109
Natural history of left ventricular hypertrophy in infants of diabetic mothers 102
Multimodality Imaging in Cardiomyopathies with Hypertrophic Phenotypes 100
Diagnosis and Management of Cardiovascular Involvement in Fabry Disease 99
Cardiovascular Involvement in mtDNA Disease: Diagnosis, Management, and Therapeutic Options 99
Diagnosis and Management of Cardiovascular Involvement in Friedreich Ataxia 99
Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study 95
Clinical, Genetic, and Histological Characterization of Patients with Rare Neuromuscular and Mitochondrial Diseases Presenting with Different Cardiomyopathy Phenotypes 93
Combined Clinical, Molecular, and Muscle Biopsy Approach to Unveil Prevalence and Clinical Features of Rare Neuromuscular and Mitochondrial Diseases in Patients With Cardiomyopathies 91
The Heart Muscle and Valve Involvement in Marfan Syndrome, Loeys-Dietz Syndromes, and Collagenopathies 91
Diagnosis and Management of Rare Cardiomyopathies in Adult and Paediatric Patients. A Position Paper of the Italian Society of Cardiology (SIC) and Italian Society of Paediatric Cardiology (SICP) 91
Medical treatment of patients with hypertrophic cardiomyopathy: An overview of current and emerging therapy 88
Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis 86
Multidisciplinary In-Depth Investigation in a Young Athlete Suffering from Syncope Caused by Myocardial Bridge 81
The Role of Genetic Testing in Patients with Heritable Thoracic Aortic Diseases 80
An atypical Aymé-Gripp phenotype detected by exome sequencing 80
Effect of beta-blockers and angiotensin receptor blockers in reducing the aortic growth rate in children with bicuspid aortic valve-related aortopathy 79
External validation of the increased wall thickness score for the diagnosis of cardiac amyloidosis 79
Global left ventricular myocardial work efficiency in heart failure patients with cardiac amyloidosis: Pathophysiological implications and role in differential diagnosis 78
Natural History of Hypertrophic Cardiomyopathy in Noonan Syndrome With Multiple Lentigines 77
Cardiovascular Involvement in Fabry's Disease: New Advances in Diagnostic Strategies, Outcome Prediction and Management 77
Aetiology and clinical manifestations of patients with non-dilated left ventricular cardiomyopathy 77
Aortic Root Diameter in Highly-Trained Competitive Athletes: Reference Values According to Sport and Prevalence of Aortic Enlargement 75
Effectiveness in the short-term of a novel nutraceutical for the management of hypercholesterolemia: an observational multicenter primary care experience 75
Immune-Checkpoint Inhibitor-Related Myocarditis: Where We Are and Where We Will Go 74
Pathophysiology, Functional Assessment and Prognostic Implications of Nutritional Disorders in Systemic Amyloidosis 74
Prevalence and clinical significance of right ventricular pulmonary arterial uncoupling in cardiac amyloidosis 74
Multimodality Imaging in Arrhythmogenic Left Ventricular Cardiomyopathy 71
The Role of New Imaging Technologies in the Diagnosis of Cardiac Amyloidosis 71
Prevalence and direct costs of patients with neuromyelitis optica: Data from Campania region in southern Italy 69
A complex unit for a complex disease: The HCM-Family Unit 69
Genetic evaluation in athletes and cascade family screening: reply 64
Genotype-Phenotype Correlations in ATTR Amyloidosis: A Clinical Update 63
Targeted Therapies in Pediatric and Adult Patients With Hypertrophic Heart Disease: From Molecular Pathophysiology to Personalized Medicine 63
Clinical pathway on pediatric cardiomyopathies: A genetic testing strategy proposed by the Italian Society of Pediatric Cardiology 63
Left Ventricular Non-Compaction in Children: Aetiology and Diagnostic Criteria 63
Resistive index of central retinal artery, aortic arterial stiffness and OCTA correlated parameters in the early stage of fabry disease 62
Amyloid Cardiomyopathies: Clinical, Diagnostic, and Therapeutic Aspects 62
Thoracic Aortic Dilation: Implications for Physical Activity and Sport Participation 61
Left ventricular rotational mechanics in cardiac amyloidosis - reply 61
The Role of Echocardiography for the Clinical Diagnosis, Risk Stratification, and Management of Cardiac Amyloidosis 60
Severe Lymphatic Disorder and Multifocal Atrial Tachycardia Treated with Trametinib in a Patient with Noonan Syndrome and SOS1 Mutation 59
A Roadmap to Predict Adverse Outcome in Fabry Disease 58
Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes 57
Clinical manifestation of patients with Fabry disease and R356W GLA variant 57
Patterns of Left Ventricular Remodelling in Children and Young Patients with Hypertrophic Cardiomyopathy 56
Prevalence of Pathogenic Variants in Cardiomyopathy-Associated Genes in Acute Myocarditis 55
An Overview of Molecular Mechanisms in Fabry Disease 55
Athlete’s Heart: A Cardiovascular Step-By-Step Multimodality Approach 54
Editorial: Paediatric Cardiomyopathies 54
Hypertrophic cardiomyopathy: prevalence of disease-specific red flags 54
Hypertrophic Cardiomyopathy-Current Challenges and Future Perspectives 53
Is There a Role for Genetic Testing in Patients With Myocarditis? 53
The role of genetic testing in Marfan syndrome 52
Prediction of radial crossover in acute coronary syndromes: Derivation and validation of the MATRIX score 51
Implantable cardioverter defibrillator in hypertrophic cardiomyopathy: Time to avoid unnecessary procedure 51
Prevalence and Clinical Significance of Intraventricular Conduction Disturbances in Hospitalized Children 51
From the phenotype to precision medicine: an update on the cardiomyopathies diagnostic workflow 50
Current Management of Transition and Multidisciplinary Care of Patients with Inherited and Rare Cardiomyopathies in Europe: Results of the European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN GUARD-HEART) 48
Diagnosis of Fabry Disease in a Patient with a Surgically Repaired Congenital Heart Defect: When Clinical History and Genetics Make the Difference 47
Sport activity in patients with cardiomyopathies: a review 46
Incidence and risk factors for development of left ventricular hypertrophy in Fabry disease 44
Next-Generation Sequencing Gene Panels in Inheritable Cardiomyopathies and Channelopathies: Prevalence of Pathogenic Variants and Variants of Unknown Significance in Uncommon Genes 44
Letter by Monda and Limongelli Regarding Article, "The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy" 44
Integrated Sudden Cardiac Death Risk Prediction Model For Patients With Hypertrophic Cardiomyopathy 44
Rare Cardiovascular Diseases: From Genetics to Personalized Medicine 43
The heart in RASopathies 42
Sudden cardiac death risk prediction in Fabry disease: How many strings do we have on our bow? 41
The Prognostic Role of Pulmonary Arterial Elastance in Patients Undergoing Left Ventricular Assist Device Implantation: A Pilot Study 40
Editorial: Cardiovascular genetics-focus on paediatric cardiomyopathy 39
Sudden cardiac death risk prediction in arrhythmogenic right ventricular cardiomyopathy: the challenge of complex statistical modelling and its impact in clinical practice 39
Letter by Monda and Limongelli Regarding Article, “Changes in Cardiac Function Following Fulminant Myocarditis” 35
Heart failure with preserved ejection fraction: the need for a better genetic characterization 35
Prognostic Implications of the Extent of Cardiac Damage in Patients With Fabry Disease 34
Expanding the knowledge on transthyretin p.V142I variant-related cardiomyopathy 34
The Italian Fabry Disease Cardiovascular Registry (IFDCR) 25
Totale 5.237
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.924
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.924
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022147 9 3 2 0 30 9 9 8 6 9 11 51
2022/2023422 38 38 6 24 49 29 3 22 182 5 14 12
2023/2024358 15 11 12 24 59 91 13 34 9 10 16 64
2024/20251.367 4 8 2 30 260 187 160 120 220 130 138 108
2025/20262.943 317 383 317 242 507 1.177 0 0 0 0 0 0
Totale 5.237